Research Article
Synthesis and In Vitro Antimicrobial and Anthelminthic Evaluation of Naphtholic and Phenolic Azo Dyes
Table 3
Antimicrobial activity of the synthesised azo compounds.
| Compounds | Pseudomonas aeruginosa | Escherichia coli | Salmonella typhi | Enterocooccus faecalis | Streptococcus pyrogenes | Staphylococcus. Aureus | Candida albicans | Minimum inhibitory concentrations (μg/mL) |
| A1 | >500 | >500 | 62.5 | 500 | 62.5 | 125 | >500 | A2 | >500 | >500 | >500 | >500 | >500 | >500 | >500 | A3 | >500 | 62.5 | >500 | >500 | 250 | >500 | 500 | A4 | >500 | 31.25 | >500 | >500 | 500 | 250 | >500 | B1 | >500 | 500 | >500 | >500 | >500 | 250 | 125 | B2 | >500 | >500 | >500 | >500 | >500 | >500 | >500 | B3 | >500 | 250 | 500 | >500 | 250 | 250 | >500 | B4 | >500 | 62.5 | 125 | >500 | >500 | 62.5 | 125 | Ciprofloxacin | ≤0.5 | ≤0.5 | ≤0.5 | 125 | 7.8 | ≤0.5 | 1 | Cefuroxime | >500 | 250 | 3.9 | 500 | 500 | 31.25 | >500 | Amoxicillin | 250 | >500 | 125 | >500 | 500 | 125 | 15.6 | Fluconazole | — | — | — | — | — | — | 500 |
|
|
A1–B4 represent the codes assigned to the synthesised compounds as shown in Table 1. |